Organovo Holdings Company
Organovo develops a range of tissue and disease models for medical research and therapeutic applications.
Technology:
Bioengineering, Organ-on-a-chip, Others
Industry:
PharmTech, Providers / R&D, Public
Headquarters:
San Diego, California, United States
Founded Date:
2007-01-01
Employees Number:
51-100
Funding Status:
IPO
Investors Number:
4
Total Funding:
112289760
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-01-29
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership